Exchange Traded Concepts, LLC Innoviva, Inc. Transaction History

Exchange Traded Concepts, LLC

$10.4 Billion
Q3 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 169,398 shares of INVA stock, worth $2.92 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

169,398

Previous 180,982 6.4%

Holding current value

$2.92 Million

Previous $3.64 Million 14.97%

% of portfolio

0.03%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	SELL	$18.17 - $20.92 $210,481 - $242,337	-11,584 Reduced 6.4%	169,398 $3.09 Million
Q2 2025 Jul 10, 2025	BUY	$17.1 - $21.8 $84,764 - $108,062	4,957 Added 2.82%	180,982 $3.64 Million
Q1 2025 Apr 17, 2025	BUY	$17.21 - $18.98 $241,284 - $266,099	14,020 Added 8.65%	176,025 $3.19 Million
Q4 2024 Jan 21, 2025	BUY	$17.35 - $20.32 $125,267 - $146,710	7,220 Added 4.66%	162,005 $2.81 Million
Q3 2024 Oct 10, 2024	SELL	$16.33 - $20.04 $453,222 - $556,190	-27,754 Reduced 15.2%	154,785 $2.99 Million
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $98,726 - $112,438	6,856 Added 3.9%	182,539 $2.99 Million
Q1 2024 Apr 15, 2024	BUY	$14.56 - $16.78 $248,932 - $286,887	17,097 Added 10.78%	175,683 $2.68 Million
Q4 2023 Jan 05, 2024	BUY	$12.32 - $16.27 $20,056 - $26,487	1,628 Added 1.04%	158,586 $2.54 Million
Q3 2023 Oct 18, 2023	SELL	$12.37 - $13.89 $234,164 - $262,937	-18,930 Reduced 10.76%	156,958 $2.04 Million
Q2 2023 Jul 20, 2023	SELL	$11.39 - $13.72 $18,793 - $22,638	-1,650 Reduced 0.93%	175,888 $2.24 Million
Q1 2023 Apr 12, 2023	BUY	$10.73 - $13.6 $285,696 - $362,113	26,626 Added 17.64%	177,538 $2 Million
Q4 2022 Jan 17, 2023	SELL	$11.8 - $13.78 $319,721 - $373,369	-27,095 Reduced 15.22%	150,912 $2 Million
Q3 2022 Oct 07, 2022	BUY	$11.61 - $15.22 $118,677 - $155,578	10,222 Added 6.09%	178,007 $2.07 Million
Q2 2022 Jul 20, 2022	BUY	$14.32 - $19.88 $76,425 - $106,099	5,337 Added 3.29%	167,785 $2.48 Million
Q1 2022 Apr 26, 2022	BUY	$15.39 - $20.25 $1.92 Million - $2.52 Million	124,545 Added 328.59%	162,448 $3.14 Million
Q4 2021 Jan 13, 2022	BUY	$15.91 - $18.72 $10,930 - $12,860	687 Added 1.85%	37,903 $654,000
Q3 2021 Oct 18, 2021	SELL	$13.06 - $17.24 $105,590 - $139,385	-8,085 Reduced 17.85%	37,216 $622,000
Q2 2021 Jul 30, 2021	BUY	$11.45 - $13.96 $53,986 - $65,821	4,715 Added 11.62%	45,301 $607,000
Q1 2021 Apr 20, 2021	BUY	$11.06 - $12.87 $201,745 - $234,761	18,241 Added 81.63%	40,586 $485,000
Q4 2020 Jan 19, 2021	BUY	$9.33 - $12.48 $31,759 - $42,481	3,404 Added 17.97%	22,345 $277,000
Q3 2020 Oct 30, 2020	BUY	$10.33 - $14.49 $195,660 - $274,455	18,941 New	18,941 $198,000

Others Institutions Holding INVA

# of Institutions

286

Shares Held

80.3M

Call Options Held

10.3K

Put Options Held

161K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.2B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Innoviva, Inc. Transaction History